Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Hannah M. Jones, PhD
SVP, PBPK Consulting
Certara UK Ltd, United Kingdom
Poster(s):
088: Development, Verification & Application of Physiologically-based Pharmacokinetic Model to Evaluate the CYP3A4-mediated Drug-Drug Interactions Potential of Omaveloxolone
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
127: Clinical & Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib as a Victim of Drug-Drug Interactions in Cancer Patients
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
129: Clinical & Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib as a Perpetrator of Drug-Drug Interactions in Cancer Patients
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
150: Real-World Application of Physiologically Based Pharmacokinetic Modeling (PBPK) in Support of Decision-Making During Drug Discovery; Guidance & Recommendations for the Utility of PBPK Impact on Candidate Selection & Human Pharmacokinetic Prediction Through Case Examples
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
196: Predictive Physiologically Based Pharmacokinetic (PBPK) Model Suggests Minimal Drug-Drug Interaction (DDI) Between PPARĪ“ Agonist Mavodelpar (REN001) & Rosuvastatin
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT
